Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug
A bacterial toxin can counteract colorectal cancer growth
What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Blocking a cancer-related pathway helps reduce spine deformities due to genetic disorder, finds new study
Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug
Design and synthesis of Zr-IR825 nanoparticles for photothermal therapy of tumour cells
AI model identifies how every country can improve its cancer outcomes
Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer
LLM treatment advice agrees with physician recommendations in early-stage HCC, but falls short in late stage
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
Therapies that target specific type of cell death may be an effective avenue for cancer treatment
Why are men more likely to develop multiple myeloma than women?